Last reviewed · How we verify
Aripiprazole depot 25 or 50 mg — Competitive Intelligence Brief
phase 3
Small molecule
Live · refreshed every 30 min
Target snapshot
Aripiprazole depot 25 or 50 mg (Aripiprazole depot 25 or 50 mg) — Otsuka Pharmaceutical Development & Commercialization, Inc..
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Aripiprazole depot 25 or 50 mg TARGET | Aripiprazole depot 25 or 50 mg | Otsuka Pharmaceutical Development & Commercialization, Inc. | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Aripiprazole depot 25 or 50 mg CI watch — RSS
- Aripiprazole depot 25 or 50 mg CI watch — Atom
- Aripiprazole depot 25 or 50 mg CI watch — JSON
- Aripiprazole depot 25 or 50 mg alone — RSS
Cite this brief
Drug Landscape (2026). Aripiprazole depot 25 or 50 mg — Competitive Intelligence Brief. https://druglandscape.com/ci/aripiprazole-depot-25-or-50-mg. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab